Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
Go back to Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 126.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.75 | 52 Week High | $118.49 | |||
| Open | $126.75 | 52 Week Low | $55.00 | |||
| Day High | $126.75 | P/E | N/A | |||
| Day Low | $126.75 | EPS | $-0.56 | |||
| Volume | 317 | |||||
